Your browser doesn't support javascript.
loading
The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective single-centre series.
McMillan, Annabel; O'Neill, Aideen T; Townsend, William; Lambert, Jonathan; Virchis, Andres; Shah, Raakhee; Menezes, Leon; Humphries, Paul; Von Both, Kirsten; Grandage, Victoria; Carpenter, Ben; Hough, Rachael; Ardeshna, Kirit M; Daw, Stephen.
Affiliation
  • McMillan A; University College London Hospitals NHS Foundation Trust, London, UK.
  • O'Neill AT; University College London Hospitals NHS Foundation Trust, London, UK.
  • Townsend W; University College London Hospitals NHS Foundation Trust, London, UK.
  • Lambert J; University College London Hospitals NHS Foundation Trust, London, UK.
  • Virchis A; University College London Hospitals NHS Foundation Trust, London, UK.
  • Shah R; University College London Hospitals NHS Foundation Trust, London, UK.
  • Menezes L; University College London Hospitals NHS Foundation Trust, London, UK.
  • Humphries P; University College London Hospitals NHS Foundation Trust, London, UK.
  • Von Both K; University College London Hospitals NHS Foundation Trust, London, UK.
  • Grandage V; University College London Hospitals NHS Foundation Trust, London, UK.
  • Carpenter B; University College London Hospitals NHS Foundation Trust, London, UK.
  • Hough R; University College London Hospitals NHS Foundation Trust, London, UK.
  • Ardeshna KM; University College London Hospitals NHS Foundation Trust, London, UK.
  • Daw S; University College London Hospitals NHS Foundation Trust, London, UK.
Br J Haematol ; 192(3): e84-e87, 2021 02.
Article in En | MEDLINE | ID: mdl-33426648
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols / Bendamustine Hydrochloride / Brentuximab Vedotin / Neoplasm Recurrence, Local Type of study: Risk_factors_studies Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: Br J Haematol Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols / Bendamustine Hydrochloride / Brentuximab Vedotin / Neoplasm Recurrence, Local Type of study: Risk_factors_studies Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: Br J Haematol Year: 2021 Document type: Article